Brinda Lakshmi Varahan, PhD’s Post

💥 Data Challenge for Cardiovascular Researchers! 💥   The Global Cardiovascular Research Funders Forum (GCRFF), in partnership with the American Heart Association, has launched the GCRFF Data Challenge. This is your opportunity to make a real impact on the future of cardiovascular and stroke research.   What's the challenge?   ✔ Analyse a rich dataset of grant funding information from GCRFF organisations using the AHA's Precision Medicine Platform. ✔Apply advanced data analytics, including AI-based approaches, to uncover insights that will guide future funding decisions. ✔Help identify knowledge gaps, unmet needs, and potential collaborations that can accelerate progress in cardiovascular research.   Why participate?   💷 Win substantial cash prises: $20,000 for the winner, $5,000 for two runners-up. 📈 Contribute to shaping the direction of cardiovascular research funding. 📑 Get published in a peer-reviewed journal, boosting your research profile. 🤝 Network and potentially collaborate with leading researchers and funding organisations globally.   How to apply:   ➡ Visit https://lnkd.in/eJbTK5-D for full details and submission guidelines.   📅 Deadline for proposals: June 10, 2024.   #ClinicalResearch #datascience #AI #researchfunding #innovation #GCRFF #GCRFFDataChallenge.

📢🔊❗❗❗💲💲💲PRIZE OPPORTUNITY FOR DATA-DRIVEN ACADEMIC RESEARCHERS! -- THE GCRFF DATA CHALLENGE 💻🫀🫀🫀♥️🌏🌎🌍 The Global Cardiovascular Research Funders Forum is inviting applications to use cutting edge data analytics tools to explore the wealth of data contained in the finding grants histories of 12 of the largest funders of cardiovascular research in the world to help them fund bigger and better for humanity's benefit!! The competition is led by the American Heart Association on behalf of the GCRFF. The winning entry gets a US $20,000 cash prize, and the two runners-up get US $5,000 each. 💲💲💲🌍🌎🌏🫀🫀🫀♥️ Cardiovascular backgrounds not required, just a knack for demonstrating the power of data in creative and innovative ways!! 🔊📢🎷Please share with your colleagues, institutions and networks!🎷📢🔊 Deadline for proposals is 10 June!! ❗❗❗👇More about the challenge and the GCRFF below👇👇👇 #GCRFF #britishheartfoundation #cardiovascular #research #dataanalysis #cardiovascularhealth #cardiovasculardisease #sciencehasnoborders #internationalcooperation

Younger me was terrified of submitting a paper to any journal - thoughts of rejection and failure were dominant; it felt like being back at school handing in an exam, and the teacher corrected it with a red pen - no feedback, no learning curve. Publishing is different; it is a communication channel with your peers, the Editor, and you to lift up your work. Keen to hear insights from Editors from #Cell #NatureMethods #Science and #BiochemicalSociety? Join us at the end of the month for our ACDS workshop on "From Pitch to Publication - Insights from Editors"

📢 Read BBMRI-ERIC’s six key messages for the next European Framework Programme (FP10) in this post. And get the full position paper here: 🔗 https://lnkd.in/d3qv8xkD This position paper aims to ensure that FP10 priorities incorporate key fields of health and life science research building on Research Infrastructures, like the European biobanking infrastructure. ❗️#FP10 topic 1: Focus on a “One Health” approach in research. “One Health” promotes cross-disciplinary scientific collaboration. Empowering research in “One Health” using existing ERICs will drive innovation at the intersection of human, animal, and environmental health.   ❗️#FP10 topic 2: Accelerate and advance research in the fields of cancer, rare diseases and paediatrics. Combatting cancer must remain a central focus for EU policy and funding to foster synergies of collaborative research initiatives in cancer in FP10.   ❗️#FP10 topic 3: Shape the European Health Data Space (EHDS). The EHDS is paramount for future breakthroughs. BBMRI-ERIC, part of the EHDS2Pilot project, explores how to optimally support EHDS implementation regarding the reuse of health data for research and policymaking.   ❗️#FP10 topic 4: Strengthen international research partnerships. Working towards global health strategies implies expanding research partnerships across all continents. Funding new collaborations in FP10 will help to align research efforts to jointly address key challenges.   ❗️#FP10 topic 5: Consolidate research efforts by enabling access to different funding initiatives. Confining Research Infrastructures to their Work Programmes is a lost chance for a wider use of their resources. FP10 needs overarching concepts across domains and dataspaces.   ❗️#FP10 topic 6: Avoid further diversification of the RI landscape. We call upon the EC to channel resources and efforts towards fortifying existing ERICs as strategic assets, and encourage close collaboration with initiatives to avoid fragmentation of the RI landscape.  

📚 We've got content! In a new case study in the Living Textbook, our experts highlight FM-TIPS, an NIH Collaboratory Trial, to describe an approach to conducting an interim reassessment of sample size in an ongoing cluster randomized trial. Learn more ➡️ https://lnkd.in/e8UW-22z We are grateful to the authors—David-Erick Lafontant, Megan McCabe, Patrick Heagerty, Liz Turner, M Bridget Zimmerman, and Emine Ozgur Bayman—for their important contribution to the Living Textbook. #biostatistics

While Long #COVID is thought to impact hundreds of thousands of people in Australia and around the world, there is little understanding into why the condition and the neurological complications linked to it occur.    A new WEHI-led project hoping to solve these unknowns has been awarded over $980,000 in funding from the Medical Research Future Fund (#MRFF) 2023 Post-Acute Sequalae of COVID-19 Grant Opportunity.      The research team hopes to unravel the molecular mechanisms in the brain that drive some neurological complications, like brain fog, and also identify biomarkers in the blood that could be used to diagnose patients at risk of developing long COVID.     The project 'Clearing the Fog: Defining the molecular mechanism of neurological PASC to identify biomarkers for Long COVID ' will be led by Dr Marcel Doerflinger, Professor Rory Bowden and Dr Maria Tanzer, in collaboration with Dr Emily Eriksson (co-lead of WEHI’s Covid Profile study), Professor Anthony Hannan (The Florey Institute) and Professor seth masters (the Hudson Institute of Medical Research).    A brilliant collaboration that could potentially lead to new treatments for long COVID in the future. https://lnkd.in/gWk9iG8D

My second PhD paper is out! Last year, I decided to sign-up for a PhD course on systematic review writing at Karolinska Institutet taught by Wim Grooten, and that was one of the best decision from that semester. The class assignment transformed into a bigger project, and really allowed me to explore a topic close to my heart: equity in trial access. When pre-screening for trial, one wishes and aspires to consider an entire patient population in the same way. However, the reality is often quite different than that. The large amount of disease registries in Sweden sparked the interest and idea in establishing a systematic approach to using registries for trial pre-screening, but before that I had to understand what the landscape looked like. Not only in ALS, my primary focus, but for all diseases, globally. A systematic review seemed like a great place to start :) Thanks to all the co-authors: Louisa Azizi, Linn Öijerstedt, Ulf Kläppe and Caroline Ingre for their help, support and feedbacks. Foucher, J., Azizi, L., Öijerstedt, L. et al. The usage of population and disease registries as pre-screening tools for clinical trials, a systematic review. Syst Rev 13, 111 (2024). https://lnkd.in/dabPSNU4

For those whose interest has peaked about "Scientific Sleuths," a good source to follow is The Retraction Watch. They keep a leaderboard running of who has the most retractions - 31 researchers are listed. When I search their database using Affiliations, here are the number of retractions per institution for 6 leading medical centers: 1. Brigham and Women's Hospital - 134 Retractions 2. MD Anderson Cancer Center - 95 Retractions 3. Massachusetts General Hospital - 74 Retractions 4. Mayo Clinic - 69 Retractions 5. Cleveland Clinic - 53 Retractions 6. Dana-Farber - 42 Retractions >Follow The Retraction Watch >https://lnkd.in/g-EwbibG >Subscribe (free) to The Retraction Watch Daily >https://lnkd.in/gNYQrZ5W

🌊 Call for Chapter Contributions! 📘 Excited to announce the call for chapters for our upcoming book titled "Healing from the Depths: Marine Metabolites in Disease Management," published by Nova Science Publishers, Inc. . Dive into the depths of marine biology and explore the therapeutic potential of marine metabolites in disease management. Editors: Pranav Kumar Prabhakar (Jha) and Dr. Tarun K. Upadhyay 📚 Tentative Themes: 1️⃣ The Ocean's Pharmacy: Unveiling Marine Metabolites 2️⃣ Harnessing the Healing Power: Marine Metabolites and Disease Mechanisms 3️⃣ Marine Metabolites as Anti-Infective Agents 4️⃣ Beyond the Shore: Marine Metabolites in Cancer Therapy 5️⃣ Neurological Disorders and Beyond: Marine Metabolites for Brain Health 6️⃣ Calming the Storm: Marine Metabolites and Inflammation Management 7️⃣ Marine Metabolites and Cardiovascular Health 8️⃣ Practical Challenges and Future Directions 9️⃣ Exploring the Untapped Potential: Emerging Trends and Research Frontiers 🔟 Collaborations and Partnerships: Uniting Marine Biology and Medicine 📅 Important Dates: 📝 Proposal Submission: April 30, 2024 📄 Full Paper Submission: May 30, 2024 𝐍𝐨 𝐩𝐮𝐛𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐜𝐡𝐚𝐫𝐠𝐞𝐬! Join us in unraveling the mysteries of the ocean's pharmacopeia and contribute to cutting-edge research in marine metabolites. Don't miss this opportunity to showcase your expertise and collaborate with leading experts in the field. Submit your proposals now! Proposal can be submitted to bookchaptercalls@gmail.com Let's explore the depths of discovery together! 🐠🔬 #MarineMetabolites #DiseaseManagement #ResearchOpportunity #CallforChapters #NovaScienceUSA #research #academic #phd

One from today. Come listen to the conversation about what methods could make research & innovation funding more fair.